Our Products

Everolimus Tablets 10 mg is a medication used to treat certain types of cancer, including advanced renal cell carcinoma (kidney cancer), neuroendocrine tumors, and breast cancer. It is also prescribed to prevent organ rejection in transplant patients. Everolimus is an mTOR (mechanistic target of rapamycin) inhibitor that works by blocking the mTOR pathway, which regulates cell growth, survival, and proliferation. By inhibiting this pathway, Everolimus slows down cancer cell growth and suppresses the immune system in transplant recipients.

The usual dosage is 10 mg taken once daily, as directed by a healthcare provider. Common side effects include mouth sores, diarrhea, fatigue, rash, and increased risk of infections due to immune suppression. Patients receiving Everolimus should be regularly monitored for changes in blood counts, liver function, and kidney function to ensure safe use of the medication.